Price
Target price
€2.41
€2.41
1.000%
0.024
1.000%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
WELL Health Technologies Corp. Stock
WELL Health Technologies Corp. gained 1.000% compared to yesterday.
Our community identified positive and negative aspects for WELL Health Technologies Corp. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the WELL Health Technologies Corp. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of WELL Health Technologies Corp. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
WELL Health Reports Record Revenue, Adjusted EBITDA, and Net Income Results for Q4 and Full Year 2023 and Raises Revenue Guidance
- WELL achieved record annual revenue of $776.1 million for 2023, an increase of 36% compared to the prior year. WELL achieved record quarterly revenues of $231.2 million in
WELL Ventures Reports a New Investment and Successful Follow-on Fundraising Activity in its Portfolio with High Quality Capital Allocators
- WELL Ventures is pleased to report that its portfolio companies continue to raise funds at attractive valuations with high quality capital allocators globally.
- Sun Life
WELL Health Reports Record Results for Q3-2023, Raises Guidance for Balance of 2023 and Provides Guidance of Over $900 Million in Revenue for 2024
- WELL achieved record quarterly revenues of $204.5 million and record Adjusted EBITDA(1) of $28.2 million in Q3-2023. This was WELL’s 19th consecutive quarter of record revenue